top of page
Cancer Vaccine Institute News
luciafw
Sep 22, 2021
New CVI paper on a Phase I/II clinical trial with on combination of Pembrolizumab with low dose carb
Ovarian cancer is a deadly disease that affects one in 78 women. While therapies that activate the immune system have been effective in...
Liliana Gutierrez
May 2, 2021
CVI research continues full steam ahead during the pandemic
What happens to cancer research in a pandemic? We know that cancer does not slow its roll in a pandemic so the CVI adapted quickly
Liliana Gutierrez
May 2, 2021
Cancer Vaccine Trial Challenges During the COVID Pandemic
Dr. Will Gwin and colleagues recently discussed the challenges cancer vaccine clinical trials faced due to the pandemic.
Liliana Gutierrez
Apr 25, 2021
Vaccine and Clinical Trials - 2020 in Review
The CVI is developing vaccines for breast, colon, ovarian, prostate, pancreatic, sarcoma, lung, and bladder cancers. While our early...
Liliana Gutierrez
Aug 26, 2020
Novel breast cancer therapy candidate Alpha-TEA enters clinical study
We're excited to announce a new clinical trail for advanced stage HER2+ breast cancer, in partnership with Veana Therapeutics.
Blog: Blog2
bottom of page